Pfizer, Inc. PFE
Pfizer, Inc. Stock Price Chart
Pfizer, Inc. Key Statistics
Fundamentals snapshot
Wall Street analyst ratings
About Pfizer, Inc.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna
This page tracks Pfizer, Inc.'s live share price, valuation multiples and the latest news. For how we source and present market data, see our methodology.
Latest Pfizer, Inc. news
We're expanding our Pfizer, Inc. coverage. In the meantime, browse the latest stock market news and live markets.
Other Healthcare stocks
Pfizer, Inc. (PFE) FAQ
What is Pfizer, Inc. (PFE)?
Pfizer, Inc. is a publicly traded company listed on NYSE under the ticker PFE. Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna
What is the PFE stock price today?
Pfizer, Inc. (PFE) is trading at $26.18, up 0.15% on the day. Prices on this page update through the trading session. This is not financial advice.
Is PFE a buy?
Wall Street analysts currently rate PFE a consensus "Buy", with an average 12-month price target of $29.19 (+11.49% vs the current price). Ratings are opinions, not guarantees — always do your own research.
When does Pfizer, Inc. report earnings?
The next Pfizer, Inc. earnings date is around May 5, 2026. Earnings dates can move — check the company's investor relations page to confirm.
Does PFE pay a dividend?
Pfizer, Inc. pays a dividend with a current yield of about 6.57% ($1.72 per share annually).
Market data is provided for information only and may be delayed. Nothing on this page is investment advice or a recommendation to buy or sell PFE. Markets are volatile and investing carries risk — always do your own research.